↓ Skip to main content

The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan

Overview of attention for article published in BMC Public Health, December 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
3 news outlets
twitter
2 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
108 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan
Published in
BMC Public Health, December 2010
DOI 10.1186/1472-698x-10-s1-s11
Pubmed ID
Authors

Kumar Perampaladas, Hassan Masum, Andrew Kapoor, Ronak Shah, Abdallah S Daar, Peter A Singer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Italy 1 <1%
Brazil 1 <1%
Unknown 105 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 21%
Student > Ph. D. Student 16 15%
Researcher 15 14%
Student > Bachelor 10 9%
Lecturer 5 5%
Other 19 18%
Unknown 20 19%
Readers by discipline Count As %
Social Sciences 15 14%
Medicine and Dentistry 14 13%
Agricultural and Biological Sciences 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Nursing and Health Professions 6 6%
Other 30 28%
Unknown 25 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2023.
All research outputs
#1,307,053
of 25,373,627 outputs
Outputs from BMC Public Health
#1,489
of 17,509 outputs
Outputs of similar age
#6,322
of 191,076 outputs
Outputs of similar age from BMC Public Health
#7
of 121 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,509 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,076 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.